Cargando…
A Novel Blood Index-Based Model to Predict Hepatitis B Virus-Associated Hepatocellular Carcinoma Recurrence After Curative Hepatectomy: Guidance on Adjuvant Transcatheter Arterial Chemoembolization Choice
BACKGROUND: Postoperative recurrence is a significant obstacle in hepatocellular carcinoma (HCC) treatment. This study aimed to construct a blood index-based model to predict hepatitis B virus-associated HCC (HBV-HCC) recurrence after curative hepatectomy. METHODS: A total of 370 patients who receiv...
Autores principales: | Zou, Yiping, Chen, Zhihong, Lou, Qi, Han, Hongwei, Zhang, Yuanpeng, Chen, Zhenrong, Ma, Zuyi, Shi, Ning, Jin, Haosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739488/ https://www.ncbi.nlm.nih.gov/pubmed/35004275 http://dx.doi.org/10.3389/fonc.2021.755235 |
Ejemplares similares
-
Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy
por: Shi, Ning, et al.
Publicado: (2020) -
A Pyroptosis-Based Prognostic Model for Immune Microenvironment Estimation of Hepatocellular Carcinoma
por: Chen, Zhihong, et al.
Publicado: (2022) -
Hepatectomy plus adjuvant transcatheter arterial chemoembolization improves the survival rate of patients with multicentric occurrence of hepatocellular carcinoma
por: Xu, Da, et al.
Publicado: (2018) -
Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report
por: Chen, Zhihong, et al.
Publicado: (2023) -
Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8(+) T Cell Infiltration
por: Zou, Yiping, et al.
Publicado: (2021)